Sertindole , 95% , 106516-24-9
Synonym(s):
1-[2-[4-[5-Chloro-1-(4-fluorophenyl)-1h-indol-3-yl]-1-piperidinyl]ethyl]-2-imidazolidinone
CAS NO.:106516-24-9
Empirical Formula: C24H26ClFN4O
Molecular Weight: 440.94
MDL number: MFCD00867749
Pack Size | Price | Stock | Quantity |
10MG | RMB343.20 | In Stock |
|
50MG | RMB1199.20 | In Stock |
|
100mg | RMB1919.20 | In Stock |
|
others | Enquire |
PRODUCT Properties
Melting point: | 95-100°C |
Boiling point: | 592.1±50.0 °C(Predicted) |
Density | 1.36 |
storage temp. | Sealed in dry,2-8°C |
solubility | DMSO: >10mg/mL |
form | solid |
pka | 14.53±0.20(Predicted) |
color | off-white |
Merck | 14,8466 |
InChIKey | GZKLJWGUPQBVJQ-UHFFFAOYSA-N |
Description and Uses
Serdolect was launched in the UK for acute and chronic schizophrenia and schizoaffective psychoses. It is synthetically available in three steps from 5chloro-l- (4-fluorophenyl)-l H-indole. Sertindole is selective for the limbic areas of the brain and has a high affinity for the serotinin 5-HT2 receptor where it behaves as an antagonist. It has weak affinity for the α1-adrenergic receptor and no affinity for dopamine D2 receptors. It is as effective as haloperidol but without the extrapyramidal symptoms. This may be a consequence of the fact that it expresses the c-fos protein in a manner different for haloperidol but similar to clozapine. It is non-sedating, long lasting (several days after a single dose) and has an atypical mode of action.
antipsychotic;Dopamine D2/Serotonin 5-HT2 receptor antagonist
Safety
Symbol(GHS) | GHS07 |
Signal word | Warning |
Hazard statements | H315-H319-H335-H413 |
Precautionary statements | P261-P305+P351+P338 |
Hazard Codes | Xi |
Risk Statements | 36/37/38 |
Safety Statements | 26 |
WGK Germany | 3 |
RTECS | NJ0621100 |
HS Code | 2933.99.6100 |